Table 2.
Patient characteristics; age (in years) and planned irradiation dose (in gray) are given as the mean± standard deviation
| N (%) | ||
|---|---|---|
| Patients included | 200 (100) | |
| Age (years) | 65.6 ±13.1 | |
| Sex | Female | 58 (29.0) |
| Male | 142 (71.0) | |
| Disease | Squamous cell carcinoma | 118 (59.0) |
| Salivary gland carcinoma | 16 (8.0) | |
| Lymphoma | 13 (6.5) | |
| CUP syndrome | 9 (4.5) | |
| Metastasis | 5 (2.5) | |
| Spinalioma | 5 (2.5) | |
| Melanoma | 3 (1.5) | |
| Neuroendocrine carcinoma | 3 (1.5) | |
| Plasmacytoma | 3 (1.5) | |
| Sarcoma | 3 (1.5) | |
| Glomus jugulare carcinoma | 3 (1.5) | |
| Other disease/no specific designationa | 19 (9.5) | |
| Metastasizedb | 24 (12.0) | |
| Cancer recurrenceb | 18 (9.0) | |
| Planned irradiation dose in Gray | 61.3 ±12.7 |
Abbreviation: CUP = carcinoma with unknown primary tumor.
a
Clivus meningioma (n = 1), multiple myeloma (n = 2), neuroblastoma (n = 1), osteomeningioma (n = 1), thyroid carcinoma (n = 1), synovial sarcoma (n = 1), no specific designation (n = 12).
b
At the time of the dental focus search, metastases or a recurrence was already present.